Language:
Instant News and Commentaries
2021-05-07
08:30
WuXi Biologics Completed Three Acquisitions to Enhance its Global Network

SHANGHAI, May 7, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed the acquisitions of a Bayer manufacturing facility in Wuppertal, Germany, the Pfizer China ("Pfizer") manufacturing facilities in Hangzhou, China as well as CMAB Biopharma Group ("CMAB").

Under the acquisition agreement signed in December 2020 with Bayer, WuXi Biologics took over the operations and assets of a Drug Substance facility (MFG19) located in Wuppertal, Germany that will include 3 x 1,000L perfusion and 6 x 2,000L fed-batch capacity with independent downstream suites. Announced in March 2021, WuXi Biologics closed the acquisition of biologics drug substance and product facilities (MFG20/DP9/DP10) from Pfizer China located in Hangzhou with 2 x 2,000L single-use bioreactors that can be expanded to 4 x 2,000L. The site also contains two state-of-the-art Drug Product (DP) manufacturing facilities, for drug product formulation and filling in vials and syringes.

The acquisition of CMAB, a biologics Contract Development and Manufacturing Organization (CDMO) with operations in Suzhou, China, was also announced in March 2021. The CDMO operations maintain facilities (MFG21/DP11) with 7,000 liters bioreactor DS capacity as well as DP manufacturing for both liquid and lyophilization fills. WuXi Biologics acquired 100% interest of CMAB, which will be renamed as WuXi Biologics (Suzhou) and operate as a wholly owned subsidiary.

All these acquired facilities are expected to be ready for GMP manufacturing in 2021 and enhance global footprints at WuXi Biologics. With these expansions, the total capacity of the company's 11 DS facilities in China, the U.S. and Germany will be increased to 150,000 liters by the end of 2021. In addition, there will be nine GMP DP facilities for vials and syringes in China, the U.S. and Germany to meet all clients' needs this year.

Dr. Chris Chen, CEO of WuXi Biologics, commented, "We're excited to complete these significant deals with Bayer, Pfizer and CBC Group and are glad to welcome the highly skilled talents to our WuXi Biologics family. In the past decade, we have continued to expand our capacities and capabilities to build a global biologics network while also strengthening the local supply chain to meet the growing outsourcing demands for biologics. With total 33 DS and DP facilities planned in five countries globally, we will continue to manufacture high-quality biologics and deliver them in a timely manner through our robust manufacturing capacity and resilient supply chains for the benefits of patients worldwide."

About WuXi Biologics

WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing. The company's history and achievements demonstrate its commitment to providing a truly one-stop service offering and strong value proposition to its global clients. As of March 22, 2021, there were a total of 361 integrated projects, including 190 projects in pre-clinical development stage, 137 projects in early-phase (phase I and II) clinical development, 32 projects in late-phase (phase III) development and 2 projects in commercial manufacturing. With total estimated capacity for biopharmaceutical production planned in China, Ireland, the U.S., Germany, and Singapore around 430,000 liters after 2024, WuXi Biologics will provide its biomanufacturing partners with a robust and premier-quality global supply chain network. For more information about WuXi Biologics, please visit www.wuxibiologics.com.

Contacts:

Media
PR@wuxibiologics.com

Investors
IR@wuxibiologics.com

 

Information Provided by PR Newswire [Disclaimer]
2021-05-06
16:43
CNOOC Limited Announces Liuhua 29-2 Gas Field Commences Production

HONG KONG, May 6, 2021 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883, NYSE: CEO, TSX: CNU) today announced that Liuhua 29-2 gas field has commenced production.

The Liuhua 29-2 gas field is located in the eastern South China Sea, 300 kilometers southeast of Hong Kong, with water depth of about 750 meters. A new subsea wellhead has been built, with 1 development well planned, which will fully utilize the existing production facilities of Liwan 3-1 gas field and other deepwater gas fields. It is expected to reach a peak production of approximately 41 million cubic feet of natural gas per day in 2021.

CNOOC Limited holds 100% interest of Liuhua 29-2 gas field and acts as the operator.

Notes to Editors:

More information about the Company is available at http://www.cnoocltd.com

*** *** *** ***
This press release includes "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995, including statements regarding expected future events, business prospectus or financial results. The words "expect", "anticipate", "continue", "estimate", "objective", "ongoing", "may", "will", "project", "should", "believe", "plans", "intends" and similar expressions are intended to identify such forward-looking statements. These statements are based on assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors the Company believes are appropriate under the circumstances. However, whether actual results and developments will meet the expectations and predictions of the Company depends on a number of risks and uncertainties which could cause the actual results, performance and financial condition to differ materially from the Company's expectations, including but not limited to those associated with fluctuations in crude oil and natural gas prices, macro-political and economic factors, changes in the tax and fiscal regimes of the host countries in which we operate, the highly competitive nature of the oil and natural gas industry, the exploration and development activities, mergers, acquisitions and divestments activities, environmental responsibility and compliance requirements, foreign operations and cyber system attacks. For a description of these and other risks and uncertainties, please see the documents the Company files from time to time with the United States Securities and Exchange Commission, including the Annual Report on Form 20-F filed in April of the latest fiscal year.

Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements. The Company cannot assure that the results or developments anticipated will be realised or, even if substantially realised, that they will have the expected effect on the Company, its business or operations.

*** *** *** ***

For further enquiries, please contact:

Ms. Jing Liu
Manager, Media & Public Relations
CNOOC Limited
Tel: +86-10-8452-3404
Fax: +86-10-8452-1441
E-mail: mr@cnooc.com.cn

Bunny Lee
Porda Havas International Finance Communications Group
Tel: +852 3150 6707
Fax: +852 3150 6728
E-mail: cnooc.hk@pordahavas.com

Related Links :

http://www.cnoocltd.com

Information Provided by PR Newswire [Disclaimer]
16:41
中海油宣佈流花29-2氣田投產

香港2021年5月6日 /美通社/ -- 中國海洋石油有限公司(「公司」或「中海油」,香港聯交所股票代碼:00883,紐約證券交易所股票代碼:CEO,多倫多證券交易所股票代碼:CNU)今天宣佈流花29-2氣田已投產。

流花29-2氣田位於南海東部海域,距香港東南約300公里,平均水深約750米。該氣田新建一座水下井口,同時依托荔灣3-1等深水氣田現有設施進行開發,計劃投產1口開發井,預計2021年將實現日產天然氣約41百萬立方英尺的高峰產量。

中海油擁有流花29-2氣田100%的權益,並擔任作業者。

編者註:

如需瞭解中國海洋石油有限公司更多信息,請登陸公司網站 http://www.cnoocltd.com

本新聞稿包含一九九五年《美國私人證券訴訟改革法案》(United States Private Securities Litigation Reform Act of 1995)意義上的前瞻性聲明,包括關於預期未來事件、業務展望或財務結果的聲明。「預期」、「預計」、「繼續」、「估計」、「目標」、「持續」、「可能」、「將會」、「預測」、「應當」、「相信」、「計劃」、「旨在」等詞彙以及相似表達意在判定此類前瞻性聲明。這些聲明以本公司根據其經驗以及對歷史發展趨勢、目前情況以及預期未來發展的理解,以及本公司相信的其它合理因素所做出的假設和分析為基礎。然而,實際結果和發展是否能夠達到本公司的預期和預測取決於一些可能導致實際業績、表現和財務狀況與本公司的預期產生重大差異的風險和不確定因素,這些因素包括但不限於與原油和天然氣價格波動有關的因素、宏觀政治及經濟因素,公司作業所在國的財稅制度變化,石油和天然氣行業高競爭性的本質,勘探開發和併購剝離活動,環境責任和合規要求,海外經營狀況以及網絡攻擊。對於這些及其他風險和不確定因素的描述,請參看本公司不時向美國證券交易委員會遞交的備案文件,包括本公司於最近財政年度四月份備案的年度報告(20-F表格)。

因此,本新聞稿中所做的所有前瞻性聲明均受這些謹慎性聲明的限制。本公司不能保證預期的業績或發展將會實現,或者即便在很大程度上得以實現,本公司也不能保證其將會對本公司、其業務或經營產生預期的效果。

如有進一步查詢,請聯絡:

劉靜
媒體/公共關係經理
中國海洋石油有限公司
電話:+86-10-8452-3404
傳真:+86-10-8452-1441
電郵:mr@cnooc.com.cn

李耀榮
博達浩華國際財經傳訊集團
電話: +852 3150 6707 
傳真: +852 3150 6728
電郵:cnooc.hk@pordahavas.com

相關鏈接 :

http://www.cnoocltd.com

Information Provided by PR Newswire [Disclaimer]
2021-05-05
10:19
【港股策略】洛陽鉏業3993 乘搭電動車材料「超級周期」

現在,該股以5.59元交易,股價上升0.43元,總成交量為4759萬股,而最新技術性量度上升首目標為6.0元,破位後將可反覆向上挑戰6.5元水平,再上可見7.0元。

洛陽鉬業公布3月止第一季度報告,按中國會計準則,受惠銅、鈷產品價格上漲,實現營業收入399.16億人民幣(下同),按年增加78.3%。錄得純利10.07億元,增長124.8%,每股收益4.7分。

洛陽鉬業於2021年4月中公布,全資子公司洛鉬控股與寧德時代(深:300750)間接控股公司邦普時代簽訂戰略合作協議,邦普時代通過全資子公司時代新能源以總對價1.375億美元獲得洛鉬控股全資子公司KFM控股25%股權。

大和發表報告指,銅價及鈷價年初至今進一步反彈,符合該行認為今年是電池/電動車材料「超級周期」的觀點,預期銅短缺問題會在今年上半年惡化,至下半年才有望緩和。

該行表示,洛陽鉬業於1月29日公布今年的生產指引,其中於剛果民主共和國的銅鈷業務指引超出該行原先預期,相信集團今年向好的生產指引,可為盈利帶來額外支持。

大和上調洛鉬股份目標價,由6.4元升至7.6元,相當預測市賬率3,25倍,維持「跑贏大市」評級,並調升集團今明兩年每股盈利預測各11.3%。

 

Information Provided by Strategist Digital Limited [Disclaimer]
2021-04-30
22:29
AAC's WLG Hybrid Camera Lens Global debut marks a new dawn in Mobile Photography

SHENZHEN, China, April 30, 2021 /PRNewswire/ -- Xiaomi's Redmi K40 Gaming Edition is the first mobile phone in the world to incorporate a Wafer Level Glass (WLG) hybrid camera lens.  The K40 Gaming Edition was officially launched on April 27th, 2021. The hybrid camera lens solution includes 1 glass + 5 plastic lens elements provided by AAC Optics, a subsidiary of AAC Technologies.  AAC Optics made their initial investment into WLG 10 years ago and has subsequently developed patented expertise to enable high volume production of Wafer Level Glass (WLG) technology into the Smartphone, Automotive, and IOT (Internet of Things) markets.

The launch represents a milestone in mobile photography. The camera touts a larger aperture and a 15% increase in light reaching the sensor, enabling lower noise and more detail for low light and night photography. The unique lens coating and anti-reflective technologies reduce ghosting and flare in complex light environments. With increased aperture, optical designers have greater design freedom for improved performance and smaller dimensions, making phones lighter and thinner.

Due to the extremely challenging manufacturing process of glass material, all mobile phones currently use plastic lenses. Leveraging semiconductor wafer manufacturing techniques, AAC Optics has demonstrated that glasses lenses can be mass produced for global smartphone supply chains. Due to the highly transferable technology, WLG is suitable for making a variety of high-precision aspheric glass lenses. This will open limitless opportunities for glass lenses to improve the end user experience in applications beyond smartphones, including automotive, AR/VR, drones, smart home devices and wearables. 

For the press kit, click here:

About AAC Technologies:
AAC Technologies Holdings Inc. is a leading solutions provider for smart devices. Our cutting-edge technologies in materials research, simulation, algorithms, design, automation and process development in Acoustics, Optics, Electromagnetic Drives and Precision Mechanics, MEMS, Radio Frequency and Antenna, enable us to develop advanced miniaturized proprietary technology solutions. Our goal is to "Lead Innovation & Enhance User Experience". In delivering high-performance and superior quality products, the Group will continue to create value for customers with innovative user experience. https://www.aactechnologies.com/

AAC Technologies is a constituent stock of the Hang Seng Index, Hang Seng Corporate Sustainability Index, Hang Seng China (Hong Kong Listed) 100 Index and MSCI China Index with HK stock code 2018.

Contact: David Plekenpol, DavidPlekenpol@aactechnologies.com

Information Provided by PR Newswire [Disclaimer]
21:42
瑞聲科技WLG玻塑混合鏡頭全球首發 手機影像正式進入玻璃鏡頭時代

深圳2021年4月30日 /美通社/ -- 全球首款搭載WLG玻塑混合鏡頭手機 -- Redmi K40 遊戲增強版,於4月27日正式發佈,該手機鏡頭採用1片玻璃鏡片+5片塑膠鏡片的解決方案,由全球唯一擁有WLG晶圓級玻璃技術的瑞聲科技旗下子公司 -- AAC OPTICS誠瑞光學提供。

通過搭載玻璃鏡片,Redmi K40 遊戲增強版的攝像頭光圈更大、進光量提升15%,在拍攝夜景時噪點更低、細節更豐富。同時,通過特有的鏡片噴塗技術和鏡片超低反鍍膜工藝,可在複雜光線下有效抑制鬼影和炫光。

這是手機影像發展史上的一個創舉。由於玻璃鏡片生產工藝難度極高,目前全球手機使用的都是塑膠鏡片,而玻璃鏡片擁有低色散、進光量大、熱穩定性的優勢,可以獲得更大的鏡頭設計自由、更大的光圈及更強的解析力,能夠讓手機攝像頭性能更好的同時變得更薄。

誠瑞光學積累了十餘年WLG技術研發與製造經驗,具備實現玻璃鏡片規模化量產的能力,產能比傳統技術高出數十倍,並可生產多種高精度非球面玻璃鏡片,有望逐步取代塑膠鏡頭,廣泛運用在智慧手機、智慧汽車、AR/VR、可穿戴設備等領域。

查看新闻资料,请点击此处。

聯繫人:David Plekenpol,DavidPlekenpol@aactechnologies.com

Information Provided by PR Newswire [Disclaimer]
16:37
China's healthcare market is expected to grow from RMB6 trillion in 2019 to RMB16 trillion in 2030

Ping An Leading Digital Revolution in Healthcare

Pandemic accelerating shift to online/offline service delivery

HONG KONG and SHANGHAI, April 30, 2021 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An" or the "Group", HKEX: 2318; SSE: 601318) is investing in a holistic strategy in digital healthcare to address the challenges of China's rapidly aging population, rising public healthcare costs and a shortage of medical professionals.

Digital healthcare spending last year was about 7% of total healthcare spending in China, but the COVID-19 pandemic has driven wider acceptance of online healthcare services among the government, regulators, health care professionals, consumers and companies, Ping An Group Co-CEO Jessica Tan said on McKinsey's Future of Asia podcast.

"We believe perhaps 20% to 25% [of healthcare services in China] could be online or even part of it can be online, but then the bulk is still going to be offline. You still need to solve the offline problem, and we believe that technology can be used to empower these professionals," Ms Tan said.

Ping An has used its financial and technology expertise to create a closed-loop healthcare ecosystem with 12 Group entities supporting the government, healthcare service providers, medical professionals, social and commercial health insurers, and consumers.

"Healthcare services is a critical and differentiating part of our insurance, so we've bundled our insurance and healthcare services together," Ms Tan said. "We're one of the largest online healthcare providers, and we believe that this digitization of healthcare services is coming, and we would like to be one of the leading players in this area."

China's healthcare market is expected to grow from RMB6 trillion in 2019 to RMB16 trillion in 2030, she said. There is rapid growth in demand from an aging and increasingly affluent population and a supportive policy and regulatory environment in line with the national Healthy China 2030 initiative. However, there are major challenges: with 3.8 million doctors, 4.4 million nurses for population of 1.4 billion, there is a shortfall of as many as 700,000 doctors and millions of nurses, compared to Western countries. Rising costs must also be controlled: Chinese consumers are spending as much as 10% of their disposable income on health expenses, compared with 7% for US consumers. At the same time, government social health insurance expenditures are growing faster than income, so commercial insurance, which only represents about 7% of the payments, can grow to relieve the burden of the out-of-pocket expenditure, Ms Tan said.

Ping An Good Doctor, the first pillar of Ping An's healthcare strategy, is already the leading online healthcare services portal in China, for 24/7 online consultations, health management, prescriptions, second medical opinions and drug delivery. As of December 31, 2020, Ping An Good Doctor had 373 million users, and partnered with more than 3,700 hospitals and 151,000 pharmacies.

The second pillar is to support medical professionals working offline, with tools such as AskBob Doctor, an artificial intelligence (AI)-driven clinical decision support system and AI medical imaging and analysis. AskBob Doctor is already supporting 250,000 medical institutions and 750,000 doctors, for faster, more accurate diagnoses and tailored treatment recommendations. These tools were developed by Ping An Smart Healthcare, affiliated to Group subsidiary Ping An Smart City. Ping An Smart Healthcare supports the development of China's health care system by improving institutional management by health and medical authorities, assisting doctors in diagnosis and treatment, supporting the public health system to manage epidemics and chronic diseases, and facilitating pharmaceutical research.

For the Ping An Group, the healthcare ecosystem plays a key role in growing the Group's core financial business. Each year for the past four years, between 15% and 20% of Ping An's new financial customers were sourced from the health care ecosystem. Those customers held an average of 3.2 financial contracts and RMB39,100 in AUM per capita, compared to an average 2.1 financial contracts and RMB17,300 in AUM per capita for those who did not use the healthcare ecosystem.

About Ping An Group
Ping An Insurance (Group) Company of China, Ltd. ("Ping An") is a world-leading technology-powered retail financial services group. With over 220 million retail customers and 611 million internet users, Ping An is one of the largest financial services companies in the world. Ping An focuses on two over-arching domains of activity, "pan financial assets" and "pan health care", covering the provision of financial and health care services through our integrated financial services platform and our ecosystems; in financial services, health care, auto services and smart city services. Our "finance + technology" and "finance + ecosystem" transformation strategies aim to provide customers and internet users with innovative and simple products and services using technology. As China's first joint stock insurance company, Ping An is committed to upholding the highest standards of corporate reporting and corporate governance. The Group is listed on the stock exchanges in Hong Kong and Shanghai. In 2020, Ping An ranked 7th in the Forbes Global 2000 list and ranked 21st in the Fortune Global 500 list. Ping An also ranked 38th in the 2020 WPP Kantar Millward Brown BrandZTM Top 100 Most Valuable Global Brands list.

For more information, please visit www.group.pingan.com and follow us on LinkedIn - PING AN.

Related Links :

http://www.pingan.cn

Information Provided by PR Newswire [Disclaimer]
06:08
PetroChina Filed Annual Report on Form 20-F

BEIJING, April 30, 2021 /PRNewswire/ -- PetroChina Company Limited ("PetroChina" or the  "Company", SEHK stock code 0857; NYSE symbol PTR; SSE stock code 601857) announced today that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2020 with the United States Securities and Exchange Commission (the "SEC"), which includes its audited financial statements.

The report can be accessed through SEC's website www.sec.gov and the Company's website www.petrochina.com.cn.  A soft copy of the report in pdf format is available for download through the Company's website. Upon request by a shareholder, the Company will deliver a hard copy of the report free of charge within a reasonable time.

To request a hard copy of the annual report, please contact:

BNY Mellon Shareowner Services
P.O. BOX 505000
Louisville, KY 40233-5000
UNITED STATES

Overnight correspondence should be sent to:
BNY Mellon Shareowner Services
462 South 4th Street Suite 1600
Louisville, KY 40202
UNITED STATES

Calling from within the US and Canada (toll-free): 1 888 269 2377
International call: 1-201-680-6825
Email: shrrelations@cpushareownerservices.com

Additional information on PetroChina is available at its website:
http://www.petrochina.com.cn

Related Links :

http://www.petrochina.com.cn

Information Provided by PR Newswire [Disclaimer]
2021-04-29
20:55
Ping An Ranked the World's Most Valuable Insurance Brand For Fifth Year in a Row

HONG KONG and SHANGHAI, April 29, 2021 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An" or the "Group", HKEx:2318; SSE:601318) announced that Ping An is the world's most valuable insurance brand, with a brand value of USD44.8 billion, in the Insurance 100 2021 Ranking by leading brand valuation consultancy Brand Finance. Ping An has retained the top spot as the world's most valuable insurance brand for the fifth year in a row.

Brand Finance is the world's leading independent brand valuation consultancy. It evaluates thousands of the world's biggest brands every year. The Insurance 100 2021 ranking evaluates aspects of the brands' industry performance, brand equity, and contribution to business performance. Brand Finance feeds these factors into the Brand Strength Index (BSI) and quantifies the brand values. This year, Brand Finance also assessed the impact of the COVID-19 outbreak on enterprise value, estimating the likely impact on brand value for each sector.

Brand Finance said, "As predicted, insurance brands have taken a hit this year as they negotiate the fallout from the pandemic … They have, however, fared better than our initial predictions at the outbreak of last year, demonstrating the resilience of the world's top insurance brands. Ping An has already begun to show signs of a strong recovery as parts of the world begin to remerge from the pandemic, and therefore, if this trend continues, Ping An should see a solid increase in brand value in the coming year."

Ping An continued to strengthen its technological capabilities and provide high quality products and services to clients amid the COVID-19 pandemic. In the first quarter of 2021, Ping An achieved steady business results. The Group achieved operating profit attributable to shareholders of the parent company of RMB39,120 million, up 8.9% year-on-year. In addition, the Group promoted annuity products, improved its protection product portfolio by developing new "product + service" packages for healthy business development. New business value of the life and health insurance business rose by 15.4% year-on-year to RMB18,980 million. Operating profit rose steadily by 4.2% year-on-year to RMB25,580 million. Ping An's retail customers also continued to increase. By the end of March, Ping An's retail customers grew 1.0% in the year-to-date to more than 220 million, including 84.57 million, or 38.3%, who hold multiple contracts with different Group subsidiaries.

Ping An said: "While pursuing steady progress by continuously advancing our 'finance + technology' and the 'finance + ecosystem' strategies, Ping An adheres to the philosophy of 'expertise makes life simple, technology makes financial services heartwarming, and healthcare makes life better'. In the future, Ping An will seize the development opportunities of fintech and healthtech, support the development of smart cities, fulfill social responsibilities and protect society and people's livelihoods."

In addition to Ping An, Chinese insurance brands in general have a significant presence in the Brand Finance Insurance 100 2021 ranking. A total of 12 Chinese insurers are featured, with Ping An, China Life, AIA, CPIC and PICC in the top 10. The cumulative brand value of the 12 Chinese insurance brands accounts for 30% of the total brand value of Insurance 100 2021.

About Ping An Group

Ping An Insurance (Group) Company of China, Ltd. ("Ping An") is a world-leading technology-powered retail financial services group. With over 220 million retail customers and 611 million internet users, Ping An is one of the largest financial services companies in the world. Ping An focuses on two over-arching domains of activity, "pan financial assets" and "pan health care", covering the provision of financial and health care services through our integrated financial services platform and our ecosystems; in financial services, health care, auto services and smart city services. Our "finance + technology" and "finance + ecosystem" transformation strategies aim to provide customers and internet users with innovative and simple products and services using technology. As China's first joint stock insurance company, Ping An is committed to upholding the highest standards of corporate reporting and corporate governance. The Group is listed on the stock exchanges in Hong Kong and Shanghai. In 2020, Ping An ranked 7th in the Forbes Global 2000 list and ranked 21st in the Fortune Global 500 list. Ping An also ranked 38th in the 2020 WPP Kantar Millward Brown BrandZTM Top 100 Most Valuable Global Brands list.

For more information, please visit www.group.pingan.com and follow us on LinkedIn - PING AN.

Related Links :

http://www.pingan.cn

Information Provided by PR Newswire [Disclaimer]
19:30
China Life Announces Filing of 2020 Annual Report on Form 20-F

BEIJING, April 29, 2021 /PRNewswire/ -- China Life Insurance Company Limited (the "Company") (NYSE: LFC; HKSE: 2628; SSE: 601628), announced that the Company has filed its 2020 Annual Report on Form 20-F (the "2020 Form 20-F"), which includes its audited financial statements for the fiscal year ended December 31, 2020, with the United States Securities and Exchange Commission.

The Company has made available through its website (www.e-chinalife.com) its 2020 Form 20-F, which can also be accessed electronically at www.sec.gov. Upon request by any shareholder or ADR holder, the Company will also deliver, free of charge and within a reasonable period of time after such request, a hard copy of its complete audited financial statements for the fiscal year ended December 31, 2020.

To request a hard copy of the audited financial statements, please send your request by mail to the following address:

Proxy Services Corporation
2180 5th Avenue - Suite #4
Ronkonkoma, NY 11779

Related Links :

http://www.e-chinalife.com

Information Provided by PR Newswire [Disclaimer]